{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-009061","form_type":"8-K/A","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2023-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.231810+00:00","generated_at":"2026-06-07T08:37:38.584468+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aethlon Medical sets compensation for Frakes as Interim CEO ($500K salary) and Cipriani as COO ($390K)","bullets":["James Frakes appointed Interim CEO effective Nov 7, 2023; base salary raised from $360K to $500K while in role.","Guy Cipriani appointed SVP & COO effective Nov 7, 2023; base salary set at $390K; resigned from Board.","Frakes also remains CFO and joined Board; salary may revert upon hiring of permanent CEO.","Cipriani resigns from Board per terms; reports to Interim CEO then to new CEO when appointed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-009061","json":"https://secwatch.observer/filing/0001683168-23-009061.json","markdown":"https://secwatch.observer/filing/0001683168-23-009061.md","text":"https://secwatch.observer/filing/0001683168-23-009061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/aethlon_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T08:37:38.584468+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1813808e87","claim":"Guy F. Cipriani was appointed as Senior Vice President and Chief Operating Officer at AETHLON MEDICAL INC.","evidence_excerpt":"Effective as of the Effective Date, Guy F. Cipriani, formerly Senior Vice President and Chief Business Officer of the Company, (i) was appointed as the Company’s Senior Vice President and Chief Operating Officer and (ii) resigned from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President and Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"5ae916fe3d","claim":"Charles J. Fisher, Jr., M.D. departed as Chief Executive Officer at AETHLON MEDICAL INC.","evidence_excerpt":"(b) Departure of Charles J. Fisher, Jr., M.D. as Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"8c3a7fd159","claim":"Guy F. Cipriani resigned as Director at AETHLON MEDICAL INC.","evidence_excerpt":"Resignation of Guy F. Cipriani as Director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c5eb719b0c","claim":"James B. Frakes was appointed as Interim Chief Executive Officer at AETHLON MEDICAL INC.","evidence_excerpt":"Effective as of the Effective Date, Mr. Frakes, Chief Financial Officer of the Company, was appointed as (i) Interim Chief Executive Officer of the Company, replacing Dr. Fisher, and (ii) a member of the Board of Directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"db7b646df6","claim":"James B. Frakes was appointed as Member of the Board of Directors at AETHLON MEDICAL INC.","evidence_excerpt":"Effective as of the Effective Date, Mr. Frakes, Chief Financial Officer of the Company, was appointed as (i) Interim Chief Executive Officer of the Company, replacing Dr. Fisher, and (ii) a member of the Board of Directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823009061/0001683168-23-009061-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}